Journals / Astım Allerji İmmünoloji / 2015 / Cilt: 13 - Sayı: 2

Steven-Johnson syndrome caused by concomitant use of valproic acid and lamotrigine: how safe is combined antiepileptic drug usage?

Valproik asit ve lamotrijin kullanımına sekonder Valproik asit ve lamotrijin kullanımına sekonder gelişen Steven-Johnson sendromu: Kombine gelişen Steven-Johnson sendromu: Kombine antiepileptik kullanımı ne kadar güvenli? antiepileptik kullanımı ne kadar güvenli?

Pages
97–99
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We have reported this rare clinical entity to emphasize probable serious mucocutaneous reactions caused by combined antiepileptic usage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Steven-Johnson syndrome is a rare but life-threatening mucocutaneous adverse reaction that usually caused by drugs.
📊
Key Findings & Data:Sulfonamides, anticonvulsants, salicylates, penicilline, amoxicilline and isoniazid are the most accused drugs.
💡
Conclusion & Impact:We have reported this rare clinical entity to emphasize probable serious mucocutaneous reactions caused by combined antiepileptic usage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Steven-Johnson syndrome is a rare but life-threatening mucocutaneous adverse reaction that usually caused by drugs. Sulfonamides, anticonvulsants, salicylates, penicilline, amoxicilline and isoniazid are the most accused drugs. Beside medications, some infectious microorganism such as herpes simplex virus, streptococci, adenovirus and mycoplasma may play a role in triggering. Altı years old girl patient presented with acute onset and widely distributed mucocutaneous vesiculobullous lesions. She had been under valproic acit treatment for one year because epilepsy and she had not any complaint of rash. Lesions appeared three weeks aft er combination of lamotrigine with valproic acid. We have reported this rare clinical entity to emphasize probable serious mucocutaneous reactions caused by combined antiepileptic usage.

Özet

Sıklıkla ilaçlara bağlı olarak gelişen ve mukokütanöz bir cilt reaksiyonu olan Steven-Johnson sendromu, nadir olarak görülen fakat hayatı tehdit edebilen bir tablodur. Etyolojide suçlanan ilaçların başında sülfonamidler, antikonvülzanlar, salisilatlar, penisilin, ampisilin ve izoniazid gelmektedir. İlaçlar dışında herpes simpleks virüs, streptokok, adenovirüs ve mikoplazma gibi infeksiyöz mikroorganizmalar tetikleyici rol oynayabilmektedir. Epilepsi tanısıyla bir yıldır valproik asit tedavisi alan ve herhangi bir döküntü şikayeti olmayan altı yaşında kız hasta, tedavinin lamotrijin ile kombine edilmesinden üç haft a sonra, deri ve mukozalarda akut olarak başlayan, yaygın vezikülobüllöz lezyonlarla başvurdu. Tablonun nadir görülmesi ve kombine antiepileptik kullanımının ciddi mukokütanöz ilaç reaksiyonlarını tetikleyebileceğini vurgulamak için olgumuzu sunuyoruz.

🔖

Cite This Article

ELMAS, Ö. F., KIZILYEL, O., GÖRGÜN, M., METİN, M. S., ATASOY, M. (2015). Steven-Johnson syndrome caused by concomitant use of valproic acid and lamotrigine: how safe is combined antiepileptic drug usage?. Astım Allerji İmmünoloji, Cilt: 13 - Sayı: 2, 97–99. https://ajindex.com/articles/150448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Borchers AT, Lee JF, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Auto immun Rev 2008;7:598-605. Dahl MV. Reactive erythemas. In: Orkin M, Maibach HI, Dahl MV (eds). Dermatology. Appleton & Lange, Norwalk, 1990:422- 36. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxicepidermal necrolysis in new users of antiepileptics. Neurology 2005;64:1134-8.
  2. Sachs B, Rönnau AC, von Schmiedeberg S, Ruzicka T, Gleichmann E, Schuppe HC. Lamotrigine-induced Stevens-Johnson syndrome: demonstration of specificlymphocytereactivity in vitro. Dermatology 1997;195:60-4.
  3. Kanner AM, Frey M. Adding valproate to lamotrigine: a study of their pharmaco kinetic interaction. Neurology 2000;55:588-91.
  4. Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, et al. Lamotrigine associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-91.